Nasal TB Vaccine Shows Promise in Johns Hopkins Study

Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease.

Early tests show it could shorten treatment times and prevent drug-resistant strains.